GGrantIndex
← Search

NOVEL DRUG/RECEPTOR CODELIVERY TO THE LIVER-LUNG AXIS TO OVERCOME GLUCOCORTICOID RESISTANCE AND ACUTE RESPIRATORY DISTRESS SYNDROME IN SEPSIS

$325,984FY2025Defense Health AgencyDOD

The Research Foundation For The State University Of New York

Investigators

View source on USAspending →
NOVEL DRUG/RECEPTOR CODELIVERY TO THE LIVER-LUNG AXIS TO OVERCOME GLUCOCORTICOID RESISTANCE AND ACUTE RESPIRATORY DISTRESS SYNDROME IN SEPSIS · GrantIndex